Metronomic capecitabine as second-line treatment in hepatocellular carcinoma after sorafenib failure.
about
Combination treatment including targeted therapy for advanced hepatocellular carcinomaEfficacy of low dose capecitabine and sorafenib in patients with advanced alfa-fetoprotein secreting hepatocellular carcinoma: a 1 year experience.Metronomic capecitabine versus best supportive care as second-line treatment in hepatocellular carcinoma: a retrospective study.Postsorafenib systemic treatments for hepatocellular carcinoma: questions and opportunities after the regorafenib trial.Regorafenib for the treatment of unresectable hepatocellular carcinoma.New chemical treatment options in second-line hepatocellular carcinoma: what to do when sorafenib fails?Extrahepatic metastasis of hepatocellular carcinoma to the paravertebral muscle: A case report.The role of metronomic capecitabine for treatment of recurrent hepatocellular carcinoma after liver transplantation.Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation.Management of pediatric hepatocellular carcinoma: A multimodal approach.Metronomic capecitabine vs. best supportive care in Child-Pugh B hepatocellular carcinoma: a proof of concept.Sustained complete response of advanced hepatocellular carcinoma with metronomic capecitabine: a report of three casesSystemic treatments for hepatocellular carcinoma: challenges and future perspectives
P2860
Q28077738-16F8001C-0245-4C65-A0AF-C0F3EA174C50Q37293105-D8B79CB4-5D13-4A80-932A-816B435F877EQ37637994-FD403287-BFFC-46F0-945A-06552B6B519BQ38660065-314FCAE8-C393-44DF-A347-5DAF8A5F355CQ38674803-C2DE818E-DCCF-48F6-BBA0-65CD1E010E41Q39010098-DA0629B8-AF29-49F2-8665-322F05EC40EEQ40070928-6E0A6C51-E642-4DF2-8E25-EED287033896Q41199454-CBD42363-6261-4DFB-A505-8621B8462888Q48105164-E0CAEE82-43E3-4C42-9D36-EA0CEFA2C336Q48252418-EB87A014-FC2A-4AB6-B52B-AA0F1CD740E8Q55646454-D5B76E16-78AE-41C2-8E7C-FA05A61FACB2Q56378351-45F9E82F-BF09-456B-A2EB-ECD7145B37B7Q57301434-917DF10A-93E5-4299-8473-485E5CD56C96
P2860
Metronomic capecitabine as second-line treatment in hepatocellular carcinoma after sorafenib failure.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Metronomic capecitabine as sec ...... inoma after sorafenib failure.
@en
type
label
Metronomic capecitabine as sec ...... inoma after sorafenib failure.
@en
prefLabel
Metronomic capecitabine as sec ...... inoma after sorafenib failure.
@en
P2093
P50
P1476
Metronomic capecitabine as sec ...... cinoma after sorafenib failure
@en
P2093
Eleonora Terzi
Francesca Benevento
Laura Venerandi
Luigi Bolondi
Matteo Renzulli
P304
P356
10.1016/J.DLD.2015.03.010
P577
2015-03-18T00:00:00Z